If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
8
Followers on Owler
BioPharmX
researches, develops and commercializes novel prescription products for pharmaceutical and women’s health markets...
Read more
Overview
Competitors
Funding
News & Insights
BioPharmX
researches, develops and commercializes novel prescription products for pharmaceutical and women’s health markets...
Read more
CEO
David S. Tierney
CEO Approval Rating
81/100
Weigh In
2010
Menlo Park
California
San Francisco Bay Area
Public
NYSE
BPMX
Pharmaceuticals & Biotechnology
Pharmaceuticals
2834
NAICS listing
http://www.biopharmx.com
Annual Revenue
$ < 1M
Employees
28
Funding
$6.8M
News
Latest News
May 20, 2020
NJBIZ
BioPharmX: Drugmakers close merger, secure $25M financing
May 15, 2020
BioSpace
BioPharmX: BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020
May 13, 2020
BioSpace
BioPharmX: BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting
May 12, 2020
Seeking Alpha
BioPharmX: BioPharmX shareholders back tie-up with Timber Pharmaceuticals
Apr 27, 2020
PR Newswire
Press Release: BioPharmX : BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time
Apr 27, 2020
BioSpace
BioPharmX: BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time
Mar 24, 2020
BioSpace
BioPharmX: BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading
Mar 02, 2020
centralcharts
Press Release: BioPharmX : BioPharmX Corporation - BPMX Stock Chart Technical Analysis for 03-02-2020
Jan 30, 2020
centralcharts
Press Release: BioPharmX : BioPharmX Corporation - BPMX Stock Chart Technical Analysis for 01-30-2020
Jan 29, 2020
The Pharma Letter
BioPharmX: Timber takes reverse IPO route to fund orphan dermatology candidates
Follow and Get Alerts
BioPharmX Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 12 + competitors
Trending Companies